Duration of antiviral immunity after smallpox vaccination
- PMID: 12925846
- DOI: 10.1038/nm917
Duration of antiviral immunity after smallpox vaccination
Abstract
Although naturally occurring smallpox was eliminated through the efforts of the World Health Organization Global Eradication Program, it remains possible that smallpox could be intentionally released. Here we examine the magnitude and duration of antiviral immunity induced by one or more smallpox vaccinations. We found that more than 90% of volunteers vaccinated 25-75 years ago still maintain substantial humoral or cellular immunity (or both) against vaccinia, the virus used to vaccinate against smallpox. Antiviral antibody responses remained stable between 1-75 years after vaccination, whereas antiviral T-cell responses declined slowly, with a half-life of 8-15 years. If these levels of immunity are considered to be at least partially protective, then the morbidity and mortality associated with an intentional smallpox outbreak would be substantially reduced because of pre-existing immunity in a large number of previously vaccinated individuals.
Comment in
-
Keeping the lock on smallpox.Nat Med. 2003 Sep;9(9):1115-6. doi: 10.1038/nm0903-1115. Nat Med. 2003. PMID: 12949522 No abstract available.
Similar articles
-
Antiviral immunity following smallpox virus infection: a case-control study.J Virol. 2010 Dec;84(24):12754-60. doi: 10.1128/JVI.01763-10. Epub 2010 Oct 6. J Virol. 2010. PMID: 20926574 Free PMC article.
-
Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.J Infect Dis. 2004 Oct 1;190(7):1286-94. doi: 10.1086/423848. Epub 2004 Aug 30. J Infect Dis. 2004. PMID: 15346340 Clinical Trial.
-
The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.Clin Microbiol Infect. 2007 Jan;13(1):91-3. doi: 10.1111/j.1469-0691.2006.01576.x. Clin Microbiol Infect. 2007. PMID: 17184294
-
Immunity and immunological memory following smallpox vaccination.Immunol Rev. 2006 Jun;211:320-37. doi: 10.1111/j.0105-2896.2006.00392.x. Immunol Rev. 2006. PMID: 16824139 Review.
-
[Jenner's cowpox vaccine in light of current vaccinology].Verh K Acad Geneeskd Belg. 1996;58(5):479-536; discussion 537-8. Verh K Acad Geneeskd Belg. 1996. PMID: 9027132 Review. Dutch.
Cited by
-
Development of Smallpox Antibody Testing and Surveillance Following Smallpox Vaccination in the Republic of Korea.Vaccines (Basel). 2024 Sep 26;12(10):1105. doi: 10.3390/vaccines12101105. Vaccines (Basel). 2024. PMID: 39460271 Free PMC article.
-
Assessing vaccine strategies for mpox outbreak in New York City using an age-structure model.BMC Infect Dis. 2024 Sep 30;24(1):1078. doi: 10.1186/s12879-024-09551-2. BMC Infect Dis. 2024. PMID: 39350073 Free PMC article.
-
Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022.Euro Surveill. 2024 Aug;29(34):2400139. doi: 10.2807/1560-7917.ES.2024.29.34.2400139. Euro Surveill. 2024. PMID: 39176988 Free PMC article.
-
Mpox: what sexual health physicians need to know?Int J Impot Res. 2024 Sep;36(6):556-561. doi: 10.1038/s41443-024-00964-w. Epub 2024 Aug 17. Int J Impot Res. 2024. PMID: 39154147 Review.
-
Smallpox vaccination campaigns resulted in age-associated population cross-immunity against monkeypox virus.J Gen Virol. 2024 Jun;105(6):001999. doi: 10.1099/jgv.0.001999. J Gen Virol. 2024. PMID: 38861287
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical